ÂÜÀòÂÒÂ×

Kirk Tilly, MBA, is a seasoned sales professional with extensive experience in the infectious disease sector, particularly in HIV medication and diagnostics. Currently serving as Injectable Sales-HIV at ViiV Healthcare since November 2019, Kirk is involved in launching HIV injectable medications, having previously promoted oral medications. In prior roles, Kirk held positions such as Key Account Manager at Theratechnologies and Regional Account Manager at Chembio Diagnostic Systems, focusing on sales and market development for infectious disease tests. Kirk's career also includes significant contributions at Abbott and Trinity Biotech, where strategic planning and market share growth in the HIV space were key responsibilities. Kirk's journey began with a role in diabetes sales at Novo Nordisk Pharmatech A/S, and educationally, Kirk holds an MBA from Western Carolina University and a Bachelor’s degree from the University of North Carolina at Greensboro.